Consistent with our findings, recent studies have found that the coexistence of anti-MDA5 and anti-Ro52 correlates with an increased frequency of RP-ILD and poor prognosis in anti-MDA5 DM patients (25). Here, IFIH1 is linked to interstitial lung disease.